Compound Detail

CHEMBL4855438

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CNc1ccc2c(cc1=O)[C@@H](NC(=O)OCC(Cl)Cl)CCc1cc(OC)c(OC)c(OC)c1-2

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4855438
Phase	Preclinical
Structure Type	MOL
InChI Key	UVJAZYYXJLBRNY-HNNXBMFYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

497.4

MW (Da)

4.30

ALogP

HBA

HBD

95.1

PSA (Å²)

0.55

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 9.4

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
LoVo CHEMBL614721	IC50	9.4	9.4	0.4	1
MCF7 CHEMBL387	IC50	9.1	9.1	0.8	1
A549 CHEMBL392	IC50	9.05	9.05	0.9	1
BALB/3T3 CHEMBL613876	IC50	8.96	8.96	1.1	1
Unchecked CHEMBL612545	IC50	8.14	8.14	7.2	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
LoVo	IC50	=	0.4	nM	9.4	Antiproliferative activity against human LoVo cells assessed as inhibition of ce...	33611191
MCF7	IC50	=	0.8	nM	9.1	Antiproliferative activity against human MCF7 cells assessed as inhibition of ce...	33611191
A549	IC50	=	0.9	nM	9.05	Antiproliferative activity against human A549 cells assessed as inhibition of ce...	33611191
BALB/3T3	IC50	=	1.1	nM	8.96	Cytotoxicity against mouse BALB/3T3 cells assessed as inhibition of cell growth ...	33611191
Unchecked	IC50	=	7.2	nM	8.14	Antiproliferative activity against human Lovo/DX cells assessed as inhibition of...	33611191

PubMed	DOI	Target Context	# Activities
33611191	10.1016/j.ejmech.2021.113282	Unchecked	2
33611191	10.1016/j.ejmech.2021.113282	LoVo	1
33611191	10.1016/j.ejmech.2021.113282	A549	1
33611191	10.1016/j.ejmech.2021.113282	MCF7	1
33611191	10.1016/j.ejmech.2021.113282	BALB/3T3	1
33611191	10.1016/j.ejmech.2021.113282	ADMET	1

Data from ChEMBL 36 via Core Engine